COMMUNIQUÉS West-GlobeNewswire
-
Marlyn Expands Solid-Dose CDMO Capabilities with a Mechanistic-Integrity–Driven Manufacturing Platform
07/05/2026 -
KALA BIO Announces Reverse Stock Split
07/05/2026 -
Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute
07/05/2026 -
ASHA Promotes Museum Exhibit About Stuttering for National Stuttering Awareness Week
07/05/2026 -
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07/05/2026 -
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07/05/2026 -
Biotech’s Next Wave May Already be in Motion
07/05/2026 -
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026
07/05/2026 -
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption
07/05/2026 -
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
07/05/2026 -
Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results
07/05/2026 -
InStride Health Sustains Outstanding Clinical Results in Third Annual Outcomes Report; Announces State Expansion Across East Coast
07/05/2026 -
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
07/05/2026 -
SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress
07/05/2026 -
Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
07/05/2026 -
Reporting of transactions in NTG’s shares made by persons discharging managerial responsibilities and persons closely associated with them
07/05/2026 -
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA
07/05/2026 -
Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
07/05/2026 -
Tria Federal Unveils Integrated Solutions Platform and New Website
07/05/2026
Pages